Leadartis, now known as Trimerbody Pharma, is a clinical-stage biopharmaceutical company developing proprietary therapeutic antibodies called Trimerbodies against cancer
Leadartis, now known as Trimerbody Pharma, is a clinical-stage biopharmaceutical company developing proprietary therapeutic antibodies called Trimerbodies against cancer. The company focuses on creating innovative medicines for solid tumors and aims to become a leader in this field.